Lactose (India) Ltd | 158 Cr. | 126 | 247/84.3 | 36.1 | 46.7 | 0.00 % | 12.9 % | 9.75 % | 10.0 |
MPS Pharmaa Ltd | 3.90 Cr. | 2.04 | 4.33/2.04 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
Gujarat Themis Biosyn Ltd | 4,214 Cr. | 387 | 411/192 | 94.5 | 22.8 | 0.18 % | 27.3 % | 21.7 % | 1.00 |
Gujarat Terce Laboratories Ltd | 28.7 Cr. | 38.7 | 94.9/37.2 | | 8.73 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 30.8 Cr. | 21.0 | 29.1/17.0 | 32.1 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
Godavari Drugs Ltd | 64.9 Cr. | 86.2 | 146/79.0 | 17.1 | 57.6 | 0.00 % | 10.3 % | 10.6 % | 10.0 |
Glenmark Life Sciences Ltd | 57,840 Cr. | 2,050 | 2,286/1,275 | 43.4 | 314 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
Gennex Laboratories Ltd | 258 Cr. | 11.4 | 29.0/11.2 | 15.7 | 8.21 | 0.00 % | 12.5 % | 9.09 % | 1.00 |
Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 19.6/9.25 | 88.2 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
Fredun Pharmaceuticals Ltd | 611 Cr. | 1,295 | 1,329/635 | 26.1 | 299 | 0.05 % | 18.9 % | 15.8 % | 10.0 |
Fervent Synergies Ltd | 117 Cr. | 23.3 | 32.0/15.0 | 35.7 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
Fermenta Biotech Ltd | 985 Cr. | 335 | 449/219 | 9.42 | 123 | 0.75 % | 23.0 % | 24.9 % | 5.00 |
Fabino Enterprises Ltd | 5.46 Cr. | 26.0 | 39.0/22.8 | 42.0 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
Evoq Remedies Ltd | 9.63 Cr. | 3.87 | 9.50/2.11 | 107 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
Everest Organics Ltd | 382 Cr. | 394 | 477/112 | 61.6 | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
Entero Healthcare Solutions Ltd | 5,235 Cr. | 1,203 | 1,584/1,078 | 51.0 | 396 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
Murae Organisor Ltd | 149 Cr. | 0.73 | 1.24/0.48 | 9.82 | 1.02 | 0.00 % | 4.21 % | 5.69 % | 1.00 |
Dipna Pharmachem Ltd | 47.9 Cr. | 19.9 | 26.3/6.40 | 49.4 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
Decipher Labs Ltd | 10.9 Cr. | 10.8 | 18.9/9.61 | | 22.6 | 0.00 % | 28.4 % | 22.7 % | 10.0 |
Coral Laboratories Ltd | 186 Cr. | 521 | 999/443 | 10.1 | 563 | 0.29 % | 17.4 % | 13.1 % | 10.0 |
Concord Drugs Ltd | 65.2 Cr. | 65.2 | 67.0/26.1 | 167 | 34.1 | 0.00 % | 4.83 % | 0.88 % | 10.0 |
Colinz Laboratories Ltd | 19.7 Cr. | 43.0 | 88.7/37.9 | 41.0 | 20.7 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
Cian Healthcare Ltd | 8.99 Cr. | 3.60 | 6.74/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 18.6 Cr. | 124 | 154/59.6 | | 87.6 | 0.00 % | 3.78 % | 2.62 % | 10.0 |
Checkpoint Trends Ltd | 20.7 Cr. | 37.9 | 45.4/8.11 | 230 | 1.02 | 0.00 % | 9.17 % | 5.50 % | 10.0 |
Chandra Bhagat Pharma Ltd | 36.3 Cr. | 48.1 | 80.0/0.00 | 42.2 | 39.7 | 0.00 % | 6.48 % | 2.92 % | 10.0 |
Brawn Biotech Ltd | 6.28 Cr. | 20.9 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 42.8 % | 10.0 |
Blue Jet Healthcare Ltd | 12,893 Cr. | 744 | 1,028/464 | 36.0 | 65.3 | 0.16 % | 40.6 % | 30.8 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 96.7 Cr. | 22.4 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 12.2 Cr. | 24.1 | 46.0/17.4 | 53.0 | 18.7 | 0.00 % | 10.1 % | 6.30 % | 10.0 |
BDH Industries Ltd | 179 Cr. | 311 | 418/241 | 18.8 | 119 | 1.45 % | 17.8 % | 14.2 % | 10.0 |
Bacil Pharma Ltd | 50.3 Cr. | 35.1 | 62.6/21.1 | 45.3 | 17.7 | 0.00 % | 3.05 % | 3.00 % | 10.0 |
Aurobindo Pharma Ltd | 61,222 Cr. | 1,044 | 1,593/994 | 18.0 | 557 | 0.43 % | 14.2 % | 11.1 % | 1.00 |
Auro Laboratories Ltd | 141 Cr. | 226 | 303/170 | 204 | 69.0 | 0.00 % | 3.79 % | 4.33 % | 10.0 |
Anuh Pharma Ltd | 845 Cr. | 84.6 | 123/74.0 | 18.3 | 32.5 | 1.77 % | 17.2 % | 13.4 % | 5.00 |
ANG Lifesciences India Ltd | 33.6 Cr. | 25.7 | 62.8/21.0 | | 51.2 | 0.00 % | 4.12 % | 14.4 % | 10.0 |
Acutaas Chemicals Ltd | 12,066 Cr. | 1,475 | 1,498/696 | 63.8 | 160 | 0.10 % | 19.9 % | 16.0 % | 5.00 |
Amerise Biosciences Ltd | 4.63 Cr. | 0.70 | 1.45/0.66 | 92.5 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 248 Cr. | 32.4 | 69.5/30.0 | 13.2 | 18.3 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
Adline Chem Lab Ltd | 10.5 Cr. | 18.0 | 26.0/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 126 Cr. | 5.34 | 6.25/2.82 | 229 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
Abbott India Ltd | 66,360 Cr. | 31,250 | 37,000/25,260 | 45.7 | 1,992 | 1.52 % | 46.2 % | 35.7 % | 10.0 |
Aarti Pharmalabs Ltd | 7,984 Cr. | 884 | 972/550 | 30.0 | 220 | 0.57 % | 17.4 % | 14.5 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 197 Cr. | 70.0 | 72.8/31.3 | 47.3 | 48.8 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
Zota Health Care Ltd | 4,076 Cr. | 1,344 | 1,397/535 | | 78.1 | 0.07 % | 17.0 % | 36.0 % | 10.0 |
Wockhardt Ltd | 24,029 Cr. | 1,479 | 1,870/915 | | 268 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
Wanbury Ltd | 917 Cr. | 279 | 330/154 | 21.3 | 18.1 | 0.00 % | 34.9 % | 70.0 % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.11 % | % | 2.00 |
Venus Remedies Ltd | 614 Cr. | 459 | 568/270 | 13.1 | 420 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
Unichem Laboratories Ltd | 3,520 Cr. | 500 | 950/483 | 28.2 | 348 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
TTK Healthcare Ltd | 1,627 Cr. | 1,151 | 1,923/991 | 24.1 | 754 | 0.87 % | 9.26 % | 6.89 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,21,128 Cr. | 3,579 | 3,790/2,886 | 60.0 | 224 | 0.89 % | 27.0 % | 26.5 % | 5.00 |
Themis Medicare Ltd | 923 Cr. | 100 | 317/98.0 | | 43.7 | 0.50 % | 10.4 % | 7.65 % | 1.00 |
Syncom Formulations (India) Ltd | 1,618 Cr. | 17.2 | 27.9/14.1 | 28.4 | 3.62 | 0.00 % | 18.7 % | 15.6 % | 1.00 |
Cohance Lifesciences Ltd | 35,307 Cr. | 923 | 1,360/856 | 100 | 66.6 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
Suven Life Sciences Ltd | 5,056 Cr. | 222 | 303/102 | | 5.04 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 3,82,358 Cr. | 1,594 | 1,960/1,553 | 33.4 | 301 | 1.00 % | 20.2 % | 16.9 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,954 Cr. | 665 | 886/441 | 120 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
SMS Pharmaceuticals Ltd | 2,094 Cr. | 236 | 398/175 | 29.8 | 75.9 | 0.17 % | 12.2 % | 11.0 % | 1.00 |
SMS Lifesciences India Ltd | 336 Cr. | 1,111 | 1,750/956 | 19.5 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
Shilpa Medicare Ltd | 8,260 Cr. | 845 | 1,003/530 | 64.2 | 243 | 0.12 % | 7.82 % | 4.21 % | 1.00 |
Sequent Scientific Ltd | 4,601 Cr. | 184 | 241/111 | 152 | 28.1 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
Sanofi India Ltd | 11,723 Cr. | 5,090 | 7,490/4,146 | 32.9 | 340 | 2.30 % | 49.2 % | 47.2 % | 10.0 |
RPG Life Sciences Ltd | 3,933 Cr. | 2,378 | 2,977/1,772 | 38.0 | 321 | 0.84 % | 32.8 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 10,732 Cr. | 6,465 | 6,739/4,863 | 35.7 | 323 | 1.93 % | 47.8 % | 36.4 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 218 Cr. | 61.8 | 87.5/31.9 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
Pfizer Ltd | 23,414 Cr. | 5,118 | 6,326/3,701 | 34.6 | 922 | 0.68 % | 21.6 % | 16.4 % | 10.0 |
Par Drugs & Chemicals Ltd | 121 Cr. | 98.1 | 348/81.0 | 8.52 | 80.4 | 0.00 % | 19.5 % | 14.5 % | 10.0 |
Panacea Biotec Ltd | 2,486 Cr. | 406 | 582/244 | | 136 | 0.00 % | 4.68 % | 5.03 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,615 Cr. | 713 | 1,998/604 | 42.4 | 250 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
Neuland Laboratories Ltd | 18,551 Cr. | 14,459 | 18,100/10,060 | 141 | 1,188 | 0.08 % | 18.7 % | 14.8 % | 10.0 |
Nectar Lifescience Ltd | 327 Cr. | 14.6 | 56.5/13.0 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
Natco Pharma Ltd | 15,274 Cr. | 853 | 1,639/660 | 9.00 | 425 | 0.70 % | 32.8 % | 28.0 % | 2.00 |
Morepen Laboratories Ltd | 2,702 Cr. | 49.3 | 101/41.7 | 29.2 | 21.1 | 0.41 % | 15.1 % | 11.8 % | 2.00 |
Marksans Pharma Ltd | 7,654 Cr. | 169 | 359/165 | 21.9 | 54.4 | 0.47 % | 20.0 % | 16.8 % | 1.00 |
Mangalam Drugs and Organics Ltd | 125 Cr. | 78.8 | 142/65.5 | | 93.9 | 0.00 % | 8.20 % | 4.76 % | 10.0 |
Lyka Labs Ltd | 355 Cr. | 99.4 | 177/90.2 | 47.3 | 29.0 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
Lupin Ltd | 88,789 Cr. | 1,944 | 2,403/1,774 | 24.0 | 377 | 0.62 % | 21.3 % | 20.6 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,119 Cr. | 559 | 980/499 | 13.0 | 335 | 0.32 % | 17.6 % | 13.0 % | 10.0 |
Laurus Labs Ltd | 47,540 Cr. | 881 | 923/423 | 93.3 | 84.6 | 0.14 % | 9.47 % | 7.75 % | 2.00 |
Kwality Pharmaceuticals Ltd | 973 Cr. | 938 | 1,235/596 | 22.4 | 256 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 156 Cr. | 72.5 | 129/63.6 | | 67.8 | 0.00 % | 30.1 % | % | 10.0 |
Kopran Ltd | 855 Cr. | 177 | 370/154 | 24.5 | 107 | 1.69 % | 9.75 % | 7.64 % | 10.0 |
Kilitch Drugs (India) Ltd | 647 Cr. | 370 | 500/265 | 23.1 | 116 | 0.00 % | 17.3 % | 14.1 % | 10.0 |
Jubilant Pharmova Ltd | 17,051 Cr. | 1,070 | 1,310/802 | 35.1 | 393 | 0.47 % | 9.54 % | 9.55 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 26,884 Cr. | 1,718 | 1,998/1,303 | 39.2 | 221 | 0.90 % | 25.8 % | 20.1 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,601 Cr. | 240 | 328/152 | 37.6 | 36.1 | 1.04 % | 23.0 % | 18.6 % | 2.00 |
Ipca Laboratories Ltd | 33,870 Cr. | 1,335 | 1,758/1,168 | 37.9 | 274 | 0.30 % | 14.7 % | 12.8 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 2,845 Cr. | 96.9 | 108/57.5 | 27.0 | 57.5 | 0.83 % | 8.86 % | 6.13 % | 2.00 |
Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 750 Cr. | 102 | 151/67.2 | 34.0 | 194 | 0.00 % | 3.47 % | 3.50 % | 10.0 |
Indoco Remedies Ltd | 2,523 Cr. | 274 | 386/190 | | 111 | 0.07 % | 0.49 % | 7.02 % | 2.00 |
Hikal Ltd | 3,232 Cr. | 262 | 465/245 | 51.0 | 102 | 0.53 % | 9.85 % | 7.38 % | 2.00 |
Hester Biosciences Ltd | 1,811 Cr. | 2,129 | 2,786/1,243 | 48.2 | 369 | 0.33 % | 9.71 % | 9.18 % | 10.0 |
Gufic BioSciences Ltd | 3,576 Cr. | 357 | 504/285 | 58.5 | 60.0 | 0.03 % | 13.0 % | 12.3 % | 1.00 |
Granules India Ltd | 12,409 Cr. | 511 | 699/412 | 26.0 | 153 | 0.29 % | 15.1 % | 13.9 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 57,905 Cr. | 2,052 | 2,286/1,275 | 43.4 | 314 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 46,931 Cr. | 2,770 | 3,516/1,921 | 49.6 | 115 | 1.52 % | 63.2 % | 46.9 % | 10.0 |
Gland Pharma Ltd | 31,175 Cr. | 1,892 | 2,131/1,200 | 27.4 | 592 | 0.95 % | 15.8 % | 11.6 % | 1.00 |
FDC Ltd | 7,668 Cr. | 471 | 659/359 | 28.5 | 140 | 1.06 % | 15.9 % | 11.8 % | 1.00 |
ERIS Lifesciences Ltd | 23,552 Cr. | 1,729 | 1,910/1,097 | 60.8 | 210 | 0.43 % | 12.2 % | 12.9 % | 1.00 |
Dr Reddys Laboratories Ltd | 1,05,834 Cr. | 1,268 | 1,406/1,020 | 18.6 | 402 | 0.63 % | 22.7 % | 18.0 % | 1.00 |
Dishman Carbogen Amcis Ltd | 4,333 Cr. | 276 | 308/161 | 36.5 | 372 | 0.00 % | 2.44 % | 0.34 % | 2.00 |
Cipla Ltd | 1,25,477 Cr. | 1,553 | 1,702/1,310 | 23.3 | 386 | 0.84 % | 22.7 % | 17.8 % | 2.00 |
Caplin Point Laboratories Ltd | 16,254 Cr. | 2,138 | 2,641/1,551 | 28.8 | 375 | 0.28 % | 25.8 % | 21.7 % | 2.00 |
Brooks Laboratories Ltd | 445 Cr. | 151 | 203/95.6 | 219 | 33.3 | 0.00 % | 9.90 % | 12.2 % | 10.0 |
Bliss GVS Pharma Ltd | 1,646 Cr. | 156 | 191/105 | 15.4 | 99.7 | 0.32 % | 11.7 % | 8.36 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 69.9 Cr. | 43.0 | 92.0/40.4 | 25.0 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
Biocon Ltd | 48,625 Cr. | 364 | 406/291 | 134 | 180 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
Beta Drugs Ltd | 1,918 Cr. | 1,900 | 2,215/1,430 | 41.9 | 195 | 0.00 % | 27.3 % | 25.8 % | 10.0 |
Bal Pharma Ltd | 141 Cr. | 88.4 | 141/76.3 | 19.6 | 48.6 | 1.36 % | 10.1 % | 9.84 % | 10.0 |
Bafna Pharmaceuticals Ltd | 238 Cr. | 101 | 117/67.8 | 23.7 | 35.8 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
Astrazeneca Pharma India Ltd | 22,725 Cr. | 9,090 | 10,691/6,220 | 107 | 308 | 0.35 % | 33.4 % | 23.6 % | 2.00 |
Amrutanjan Health Care Ltd | 2,221 Cr. | 768 | 843/544 | 40.7 | 113 | 0.60 % | 22.4 % | 16.5 % | 1.00 |
Alpa Laboratories Ltd | 200 Cr. | 95.1 | 145/85.0 | 7.59 | 86.4 | 0.00 % | 15.0 % | 11.4 % | 10.0 |
Alkem Laboratories Ltd | 63,770 Cr. | 5,334 | 6,440/4,492 | 28.0 | 1,002 | 0.84 % | 20.4 % | 19.4 % | 2.00 |
Alembic Pharmaceuticals Ltd | 18,605 Cr. | 946 | 1,304/725 | 31.4 | 264 | 1.16 % | 13.0 % | 11.4 % | 2.00 |
Albert David Ltd | 457 Cr. | 801 | 1,599/763 | 72.7 | 688 | 0.62 % | 6.45 % | 4.39 % | 10.0 |
Ajanta Pharma Ltd | 32,659 Cr. | 2,614 | 3,486/2,022 | 35.1 | 303 | 1.07 % | 32.4 % | 24.9 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,806 Cr. | 340 | 571/258 | 27.8 | 127 | 1.53 % | 13.1 % | 9.54 % | 2.00 |
Aarti Drugs Limited | 4,332 Cr. | 471 | 575/312 | 24.2 | 136 | 0.21 % | 13.5 % | 13.0 % | 10.0 |
Industry Average | 18,756.17 Cr | 1,183.56 | | 49.85 | 193.71 | 0.33% | 16.34% | 15.07% | 6.18 |